Unknown

Dataset Information

0

Treg depletion in non-human primates using a novel diphtheria toxin-based anti-human CCR4 immunotoxin.


ABSTRACT: Regulatory T cells (Treg) play an important role in modulating the immune response and has attracted increasing attention in diverse fields such as cancer treatment, transplantation and autoimmune diseases. CC chemokine receptor 4 (CCR4) is expressed on the majority of Tregs, especially on effector Tregs. Recently we have developed a diphtheria-toxin based anti-human CCR4 immunotoxin for depleting CCR4(+) cells in vivo. In this study, we demonstrated that the anti-human CCR4 immunotoxin bound and depleted monkey CCR4(+) cells in vitro. We also demonstrated that the immunotoxin bound to the CCR4(+)Foxp3(+) monkey Tregs in vitro. In vivo studies performed in two naive cynomolgus monkeys revealed 78-89% CCR4(+)Foxp3(+) Treg depletion in peripheral blood lasting approximately 10 days. In lymph nodes, 89-96% CCR4(+)Foxp3(+) Tregs were depleted. No effect was observed in other cell populations including CD8(+) T cells, other CD4(+) T cells, B cells and NK cells. To our knowledge, this is the first agent that effectively depleted non-human primate (NHP) Tregs. This immunotoxin has potential to deplete effector Tregs for combined cancer treatment.

PROVIDER: S-EPMC4826841 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5134928 | BioStudies
2013-01-01 | S-EPMC3816454 | BioStudies
1000-01-01 | S-EPMC6068354 | BioStudies
2015-01-01 | S-EPMC5528803 | BioStudies
2018-01-01 | S-EPMC6319620 | BioStudies
| S-EPMC3873154 | BioStudies
| S-EPMC5744591 | BioStudies
1000-01-01 | S-EPMC4796321 | BioStudies
| S-EPMC2918804 | BioStudies
1000-01-01 | S-EPMC5122343 | BioStudies